This article is more than 5 years old. Information may no longer be current.

VIDEO: Speaker raises question of earlier alternative strategies for patients with persistent edema

BySriniVas Sadda, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BALTIMORE – A retrospective analysis of DRCR.net Protocol I data showed patients with persistent edema treated with ranibizumab demonstrated less visual gain in the long-term compared with patients who did not have persistent edema, SriniVas R. Sadda, MD, said at the Association for Research in Vision and Ophthalmology meeting here. This opens the question of whether or not alternative treatment strategies should be discussed earlier in a patient’s care, according to Sadda.